Related Experiment Video
Updated: Mar 2, 2026
06:21
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
12.3K
Active Systemic Treatment of Pancreatic Cancer
1Presented by Margaret Tempero, MD, Professor of Medicine and Director of the University of California San Francisco (UCSF) Pancreas Center, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Abstract:
By 2020, pancreatic cancer is expected to be the second most common cause of cancer-related death, exceeded only by lung cancer. During her presentation at the NCCN 22nd Annual Conference, Dr. Margaret Tempero offered an update on the current state of systemic treatment of pancreatic cancer, focusing on resectable/borderline resectable, locally advanced, and metastatic disease.
